Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Institut d'Investigacions Biomediques August Pi i Sunyer, University of Barcelona, CIBERehd, Hospital Clinic c/Villarroel 170, 08036 Barcelona, Spain.
Centre Diagnostic per la Imatge, Hospital Clinic c/Villarroel 170, 08036 Barcelona, Spain.
Nat Rev Gastroenterol Hepatol. 2014 May;11(5):308-16. doi: 10.1038/nrgastro.2013.258. Epub 2014 Jan 14.
Thrombosis of the portal venous system is a frequent and potentially life-threatening condition that can take place in a number of different clinical settings including liver cirrhosis, hepatocellular carcinoma, other solid tumours, abdominal septic foci, acute pancreatitis, haematological malignancies and congenital or acquired prothrombotic disorders. Clinical decision-making in patients with thrombosis of the portal venous system is a particularly complex process owing to the heterogeneity of the population affected by this condition and the lack of high-quality evidence from randomized controlled trials for the use of anticoagulation therapy in these patients. This Review discusses the available data regarding how imaging can provide assistance to physicians involved in this decision-making process in different clinical settings. A flowchart illustrating how to use imaging in this setting, based on current evidence and on the experience of the Vascular Liver Diseases Group of the Hospital Clinic in Barcelona, is also presented.
门静脉系统血栓形成是一种常见且可能危及生命的病症,可发生于多种不同的临床环境中,包括肝硬化、肝细胞癌、其他实体瘤、腹部感染灶、急性胰腺炎、血液系统恶性肿瘤以及先天性或获得性易栓症。由于受该病症影响的人群存在异质性,且随机对照试验中针对这些患者使用抗凝治疗的高质量证据缺乏,因此门静脉系统血栓形成患者的临床决策制定过程尤其复杂。这篇综述讨论了现有的数据,这些数据表明影像学检查如何为不同临床环境中参与该决策过程的医生提供帮助。此外,还基于现有证据和巴塞罗那 Clinic 医院血管肝病组的经验,提供了一张流程图,说明了如何在这种情况下使用影像学检查。